Skip to main
DCGO
DCGO logo

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

DocGo Inc. is poised for financial growth, with management projecting a notable increase in revenues from its hospital segment, expected to rise from approximately $200 million in 2024 to around $250 million in 2025, largely driven by medical transportation services. The company has demonstrated strong customer retention and expansion through its logistics platform, indicating a solid market presence and potential for acquiring new clients in both existing and new markets. Additionally, the strategic shift towards the payor business, coupled with a focus on improving care quality and satisfaction, positions DocGo to effectively navigate potential revenue fluctuations and capitalize on long-term growth opportunities in value-based care arrangements.

Bears say

DocGo Inc. is experiencing a significant decline in financial performance, particularly within its Mobile Health Services segment, which reported revenues of $71.8 million—9.9% lower than estimates and a staggering 52.3% year-over-year decrease. The company's adjusted EBITDA margins are now projected to be around 5%, a substantial reduction from the previous guidance of 8% to 10%, primarily attributed to increased investments and a transition away from migrant-related revenue sources. Furthermore, the adjusted EBITDA results for the recent quarter came in at $1.1 million, significantly below the anticipated figure of $13.4 million, reflecting both lower revenues and elevated operating expenses, signaling a troubling outlook for the company's profitability and growth trajectory.

DocGo (DCGO) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Strong Buy based on their latest research and market trends.

According to 8 analysts, DocGo (DCGO) has a Strong Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.